Holen Sie sich die Stockscreener-App
0.671
3.44%
0.0223
Vorhandelsmarkt:
.67
-0.001
-0.15%
Schlusskurs vom Vortag:
$0.6487
Offen:
$0.66
24-Stunden-Volumen:
152.12K
Relative Volume:
0.22
Marktkapitalisierung:
$32.57M
Einnahmen:
$19.94M
Nettoeinkommen (Verlust:
$-37.37M
KGV:
-0.6452
EPS:
-1.04
Netto-Cashflow:
$-33.38M
1W Leistung:
+18.89%
1M Leistung:
+2.55%
6M Leistung:
-50.66%
1J Leistung:
-50.30%
1-Tages-Spanne:
$0.6481
$0.6889
1-Wochen-Bereich:
$0.571
$0.7379
52-Wochen-Spanne:
$0.5301
$2.38
Werewolf Therapeutics Inc Stock (HOWL) Company Profile
Firmenname
Werewolf Therapeutics Inc
Sektor
Branche
Telefon
617-952-0555
Adresse
200 TALCOTT AVENUE, WATERTOWN
Vergleichen Sie HOWL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HOWL
Werewolf Therapeutics Inc
|
0.671 | 31.49M | 19.94M | -37.37M | -33.38M | -1.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.17 | 120.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
771.25 | 80.15B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
864.42 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
354.75 | 47.74B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
336.16 | 37.38B | 4.98B | 69.59M | 525.67M | 0.5197 |
Werewolf Therapeutics Inc Stock (HOWL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-19 | Herabstufung | Wedbush | Outperform → Neutral |
| 2024-04-03 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-08-24 | Eingeleitet | Wedbush | Outperform |
| 2023-06-06 | Fortgesetzt | Jefferies | Buy |
| 2021-09-10 | Eingeleitet | BofA Securities | Buy |
| 2021-05-25 | Eingeleitet | Evercore ISI | Outperform |
| 2021-05-25 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-05-25 | Eingeleitet | Jefferies | Buy |
| 2021-05-25 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Werewolf Therapeutics Inc Aktie (HOWL) Neueste Nachrichten
Evnin Luke, Werewolf Therapeutics director, sells $20,942 in Howl stock By Investing.com - Investing.com Nigeria
Evnin Luke, Werewolf Therapeutics director, sells $20,942 in Howl stock - Investing.com
Werewolf Therapeutics, Inc. (NASDAQ:HOWL) Short Interest Update - Defense World
Movement Recap: Can Black Hawk Acquisition Corporation ride the EV waveGlobal Markets & Growth Focused Entry Point Reports - baoquankhu1.vn
Werewolf Therapeutics (HOWL) price target decreased by 10.86% to 5.30 - MSN
Evenin Luke sells Werewolf Therapeutics (HOWL) stock for $61k By Investing.com - Investing.com Canada
Evenin Luke sells Werewolf Therapeutics (HOWL) stock for $61k - Investing.com
Luke Evnin Sells 24,678 Shares of Werewolf Therapeutics (NASDAQ:HOWL) Stock - Defense World
Growth Value: Can Werewolf Therapeutics Inc stock double in next 5 yearsPortfolio Performance Report & Expert Curated Trade Setup Alerts - Bộ Nội Vụ
Werewolf Therapeutics (HOWL) Eyes 2026 Catalysts Following FDA Guidance and Encouraging INDUKINE Results - Yahoo Finance
Evnin Luke sells Werewolf Therapeutics (HOWL) shares for $53,533 - Investing.com UK
Evnin Luke sells Werewolf Therapeutics (HOWL) shares for $53,533 By Investing.com - Investing.com Canada
Risk Analysis: Will Werewolf Therapeutics Inc. stock benefit from infrastructure spending2025 Technical Patterns & Daily Growth Stock Tips - Улправда
Is Werewolf Therapeutics Inc. stock ready for breakout2025 Growth vs Value & High Win Rate Trade Tips - ulpravda.ru
10 Stocks Under $1 That Will Explode - Insider Monkey
Werewolf Therapeutics (HOWL) upgraded to buy: Here's what you should know - MSN
Aug Analyst Calls: Can Werewolf Therapeutics Inc. stock hit analyst price targetsPortfolio Value Summary & Verified Technical Trade Signals - ulpravda.ru
How rising interest rates impact Werewolf Therapeutics Inc. stockJuly 2025 Opening Moves & Technical Analysis for Trade Confirmation - Улправда
Evnin Luke sells Werewolf Therapeutics (HOWL) stock for $45,882 - Investing.com UK
Evnin Luke sells Werewolf Therapeutics (HOWL) stock for $45,882 By Investing.com - Investing.com India
Luke Evnin Sells 34,847 Shares of Werewolf Therapeutics (NASDAQ:HOWL) Stock - Defense World
HOWL Stock Price, Forecast & Analysis | WEREWOLF THERAPEUTICS INC (NASDAQ:HOWL) - Chartmill
Will Werewolf Therapeutics Inc. stock return to pre crisis levelsAnalyst Upgrades & Capital Efficiency Improvement - bollywoodhelpline.com
Werewolf Therapeutics, Inc. (NASDAQ:HOWL) Receives Consensus Rating of “Hold” from Analysts - Defense World
Analysts Offer Insights on Healthcare Companies: Bristol-Myers Squibb (BMY) and Werewolf Therapeutics (HOWL) - The Globe and Mail
Market Moves: Is Werewolf Therapeutics Inc. stock ready for breakoutWeekly Trade Summary & Real-Time Stock Price Movement Reports - moha.gov.vn
Will Werewolf Therapeutics Inc. stock benefit from infrastructure spendingProduct Launch & Free Accurate Trade Setup Notifications - Улправда
Werewolf Therapeutics (NASDAQ:HOWL) Downgraded to “Neutral” Rating by Wedbush - Defense World
Why retail investors pile into Werewolf Therapeutics Inc. stockRisk Management & Technical Confirmation Trade Alerts - Улправда
HC Wainwright & Co. Maintains Werewolf Therapeutics (HOWL) Buy Recommendation - Nasdaq
H.C. Wainwright slashes Werewolf Therapeutics stock price target on pipeline update By Investing.com - Investing.com Nigeria
Can Werewolf Therapeutics Inc. stock hit analyst price targetsOil Prices & Capital Protection Trading Alerts - DonanımHaber
Wedbush Downgrades Werewolf Therapeutics to Neutral From Outperform Due to 'Forward Challenging' Path, Cuts Price Target to $1 From $3 - marketscreener.com
H.C. Wainwright slashes Werewolf Therapeutics stock price target on pipeline update - Investing.com Nigeria
Werewolf Therapeutics advances Inducer platform candidates - BioWorld MedTech
Werewolf Therapeutics Announces Pipeline and Business Updates - Investing News Network
Werewolf Therapeutics Updates Pipeline and Outlines 2026 Priorities - TipRanks
Werewolf Therapeutics Incplans for two INDs by mid-2027 - marketscreener.com
Werewolf Therapeutics, Inc. Announces Pipeline Update and 2026 Priorities - TradingView — Track All Markets
Finanzdaten der Werewolf Therapeutics Inc-Aktie (HOWL)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.09%
0.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):